Effect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs
Authors:
- Agha M.W. MirzaAMAgha M.W. Mirza
- Naiela E. Mbbs AlmansouriNANaiela E. Mbbs Almansouri
- Muhammad F. MuslimMMMuhammad F. Muslim
- Thahaseen Mbbs BasheerTBThahaseen Mbbs Basheer
- Sree V. UppalapatiSUSree V. Uppalapati
- Swati Mbbs LakraSLSwati Mbbs Lakra
- Hareem Mbbs FatimaHFHareem Mbbs Fatima
- Arshiya Mbbs AdhnonAAArshiya Mbbs Adhnon
- Ivo W. Mbbs FilhoIFIvo W. Mbbs Filho
- Ruqeyya Mbbs MahmoodRMRuqeyya Mbbs Mahmood
- Mahendra Mbbs KumarMKMahendra Mbbs Kumar
- Kamal Mbbs KandelKKKamal Mbbs Kandel
Open Access
- 14 August 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6665-6672
Abstract
Objective: To evaluate the effect of vitamin D supplementation on cardiovascular outcomes. Methods: After searching different databases, we retrieved and included randomized controlled trials on long-term supplementation of vitamin D (≥1-year intervention) and reporting cardiovascular outcomes. We calculated risk ratio (RR) with 95% confidence intervals (CI) for dichotomous outcomes. Results: Compared to the control group, the vitamin D group was not associated with a statistically significant decrease in the incidence of major adverse cardiovascular events (MACE) [risk ratio=0.99; 95% CI: 0.94–1.03]. We found no difference between the vitamin D group and the control group for the outcomes of incidences of myocardial infarction, heart failure, coronary revascularization, cardiovascular death, and all-cause mortality. The heterogeneity was low for all outcomes. Conclusion: According to our meta-analysis, vitamin D supplementation did not reduce major adverse cardiovascular events, other cardiovascular parameters, and all-cause mortality.Keywords
This publication has 38 references indexed in Scilit:
- Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical TrialsJAMA Cardiology, 2019
- Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment StudyJAMA Cardiology, 2017
- Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery diseaseNutrition, Metabolism and Cardiovascular Diseases, 2015
- The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysisThe Lancet Diabetes & Endocrinology, 2014
- Prevalence of Vitamin D Deficiency in Patients With Acute Myocardial InfarctionThe American Journal of Cardiology, 2011
- Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare PopulationThe American Journal of Cardiology, 2010
- Annual High-Dose Oral Vitamin D and Falls and Fractures in Older WomenJAMA, 2010
- 25-Hydroxyvitamin D and Risk of Myocardial Infarction in MenA Prospective StudyArchives of internal medicine (1960), 2008
- Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trialThe Lancet, 2005
- Calcitriol in the treatment of postmenopausal osteoporosisThe American Journal of Medicine, 1988